1Trillo-Pazos G, Everall IP. From human immunodeficiency virus (HIV) infection of the brain to dementia. Genitourin Med, 1997, 73:343-347.
2Bouwman FH, Skolasky RL, Hes D, et al. Variable progression of HIV-associated dementia. Neurology, 1998,50: 1814-1820.
3McArthur JC, Haughey N, Gartner S, et al. Human immun-odeficiency virus-associated dementia: An evolving disease. J Neurovirol, 2003, 9:205-221.
4Albright AV, Soldan SS, Gonzalez-Scarano F. Pathogenesis of human immunodeficiency virus-induced neurological disease. J Neurovirol, 2003, 9:222-227.
5Liu Y, Tang XP, McArthur JC, et al. Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neurovirol, 2000, 6: S70-S81.
6Gabuzda D, Wang J. Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis. J Neurovirol 2000, 6: S24-S32.
7Tardieu M. HIV-1-related central nervous system diseases. Curr Opin Neurol, 1999, 12: 377-381.
8Conant K, Garzino-Demo A, Nath A, et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA, 1998, 95:3117-3121.
9Puffer BA, Pohlmann S, Edinger AL, et al. CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity. J Virol, 2002, 76: 2595-2605.
10Wesselingh SL, Thompson KA. Immunopathogenesis of HIV-associated dementia. Curr Opin Neurol, 2001,14: 375-379.
4Navia BA,Jordan BD, Price RW, et al. The AIDS dementia complex: Ⅰ. Clinical features[J].Ann Neurol, 1986,19(6) :517 - 524.
5Gregory JD, Ann M, Yueming L, et al. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy[J]. AIDS,2003,17(10) : 1539 -1545.
6Wu YC, Zhao YB, Tang MG, et al. AIDS dementia complex in China [ J ]. J Clin Neuroscience, 2007,14 ( 1 ) : 8 - 11.
7Navla BA, Rostasy K.The AIDS dementia complex:clinical and basic neuroscience with implications for novel molecular theraples[J ]. Neurotox Res,2005,8( 1 2):3-24.
8Silvers JM, Marina VA, Michael YA, et al. Neurotoxicity of HIV-1 Tat protein: Involvement of DI dopamine receptor [ J ]. Neurotoxicology, 2007,28 (6) : 1184 - 1190.
9Fernandes SP, Edwards TM, Ng KT.HIV 1 protein gp120 rapidly impairs memory in chicks by interrupting the glutamate-glutamine cycle[ J ]. Neurobiol Learn Mem, 2007,87 ( 1 ) : 1 - 8.
10Rostasy KM. Inflammation and neuroaxonal injury in multiple sclerosis and AIDS dementia complex: implications for neuroprotective treatment[ J ]. Neuropediatrics, 2005,36 (4) : 230 - 239.
